Fulgent Genetics (FLGT) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to -$380.9 million.
- Fulgent Genetics' Enterprise Value fell 7585.68% to -$380.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$380.9 million, marking a year-over-year decrease of 7585.68%. This contributed to the annual value of -$262.2 million for FY2024, which is 3859.62% up from last year.
- Latest data reveals that Fulgent Genetics reported Enterprise Value of -$380.9 million as of Q3 2025, which was down 7585.68% from -$297.9 million recorded in Q2 2025.
- Fulgent Genetics' Enterprise Value's 5-year high stood at -$216.6 million during Q3 2024, with a 5-year trough of -$578.3 million in Q1 2022.
- In the last 5 years, Fulgent Genetics' Enterprise Value had a median value of -$427.0 million in 2023 and averaged -$411.7 million.
- As far as peak fluctuations go, Fulgent Genetics' Enterprise Value crashed by 169282.0% in 2021, and later skyrocketed by 5338.24% in 2024.
- Quarter analysis of 5 years shows Fulgent Genetics' Enterprise Value stood at -$443.4 million in 2021, then fell by 17.97% to -$523.0 million in 2022, then increased by 18.37% to -$427.0 million in 2023, then surged by 38.6% to -$262.2 million in 2024, then crashed by 45.3% to -$380.9 million in 2025.
- Its Enterprise Value stands at -$380.9 million for Q3 2025, versus -$297.9 million for Q2 2025 and -$324.7 million for Q1 2025.